Introduction
Arthropod-borne viruses are a diverse group of mosquito, sand-fly and tick transmitted pathogens responsible for significant diseases in humans. While traditional control methodologies have been based primarily on vector population suppression and vaccine development, focus has recently been placed on finding long term, cost-efficient and sustainable options for disease control. The intracellular endosymbiont Wolbachia has been shown to significantly suppress the replication of a broad range of viruses in Drosophila models and interestingly retained this pathogen blocking phenotype upon trans-infection into both Aedesderived cell lines and Aedes aegypti mosquitoes (Aliota et al., 2016; Moreira et al., 2009; Teixeira et al., 2008; Walker et al., 2011) . Fields trials in which Wolbachia-infected mosquitoes have been released to facilitate Wolbachia invasion of resident Ae. aegypti populations are currently underway in a number of countries (Dutra et al., 2015; Hoffmann et al., 2011; Nguyen et al., 2015) with the aim of utilizing the virus blocking properties of Wolbachia to reduce arbovirus transmission to people. However, while a significant amount of data has been accumulated on the effects of Wolbachia on transmission of major arboviruses from the Flaviviridae and Togaviridae families, relatively little is known about the taxonomic limits of virus blocking by Wolbachia (Aliota et al., 2016; Glaser and Meola, 2010; Moreira et al., 2009; Shaw et al., 2012) . To date, few studies have investigated the effect of coreplication of Wolbachia and negative sense single stranded RNA (-ssRNA) (Glaser and Meola, 2010; Parry and Asgari, 2018; Schultz et al., 2018) or double stranded RNA (dsRNA) viruses (Shaw et al., 2012) in mosquito hosts. Furthermore, as the mechanism of Wolbachiamediated suppression remains poorly understood, +ssRNA viruses which display altered tropism and transmission strategies to that of other pathogenic viruses of the same family are of interest to be assessed for suppression by Wolbachia.
With the advent of novel and more effective sequencing technologies, an increasing number of divergent, maternally transmitted mosquito-borne viruses are being described (Blitvich and Firth, 2015; . These insect-specific viruses (ISVs) are hypothesised to form life-long, persistent viral infections within their host primarily transmitted vertically between generations (Blitvich and Firth, 2015) . While the intricacies of tissue tropism are yet to be fully investigated, preliminary findings have suggested localisation of ISVs in reproductive tissues with infection of progeny either occurring during embryo development or oviposition (Bolling et al., 2011; Hall-Mendelin et al., 2016) . Similarly, analysis of Wolbachia-specific tropisms in Ae. aegypti mosquitoes have shown high density infections in reproductive tissues (Frentiu et al., 2014; Walker et al., 2011) suggesting that in a co-infected mosquito, ISVs and Wolbachia have the potential to interact. While there has been limited studies in mosquitoes to investigate this interaction (Amuzu et al., 2018) , the Ae. aegypti derived cell line Aag2 T which has been routinely utilised in Wolbachia-related research (Hussain et al., 2013; Lu et al., 2012) has been shown to be persistently infected with two ISVs; Cell fusing agent virus (CFAV; Flaviviridae) and Phasi Charoen-like virus (PCLV; Bunyaviridae) (Cammisa-Parks et al., 1992; Maringer et al., 2017; Stollar and Thomas, 1975) . Interestingly, the first report of CFAV, a +ssRNA virus, originated from this cell line as a viral agent responsible for severe cytopathic effects when supernatant harvested from these cells was inoculated onto an Ae. albopictus line (Stollar and Thomas, 1975) . Further characterisation identified this agent as a divergent insect-specific flavivirus that has been subsequently isolated from both Ae. aegypti wild caught and laboratory colony material (Bolling et al., 2015; Cammisa-Parks et al., 1992; Cook et al., 2006) . PCLV, a -ssRNA virus of the newly proposed insect-specific Goukovirus genus was initially isolated from Ae. aegypti mosquitoes from Thailand. However, recently, it was also shown to persist in the Aag2 cell line alongside CFAV (Chandler et al., 2014; Maringer et al., 2017; Marklewitz et al., 2011) .
To determine if the introduction of Wolbachia to Aag2 cells impacted the replication of these viruses, analysis undertaken by Schnettler et al. (2016) and Zhang et al. (2016) examined Aag2 cells stably-infected with wMelPop-CLA for the presence of CFAV and PCLV by RT-PCR. It was suggested by both studies that Wolbachia severely restricts the replication of CFAV. However, upon tetracycline treatment of these lines to clear Wolbachia, contradictory results were obtained where one study suggested CFAV replication could recover after the removal of Wolbachia while the other confirmed clearance of the infection. Interestingly, it was demonstrated that Wolbachia had no effect on the insect-specific bunyavirus (PCLV) known to persistently infect these lines (Schnettler et al., 2016) . To address the extent of Wolbachiamediated suppression on ISVs and more broadly the effect of this bacterium on mosquito cultures persistently infected with +ssRNA and -ssRNA viruses, mosquito cell cultures (Aag2 and RML-12) stably infected with wMel and wMelPop-CLA were assessed for CFAV and PCLV replication both prior to and following tetracycline treatments. CFAV replication was not detected in Wolbachia infected cultures nor was the virus able to be recovered upon passage in the highly permissive RNAideficient Ae. albopictus (C6/36) cell line. Conversely, PLCV was detected and isolated from both Wolbachia infected cell lines.
Results

wMel and wMelPop-CLA suppresses CFAV in Aag2 cell line
The Ae. aegypti cell line Aag2 has been shown to be infected with two insect-specific viruses (ISVs) (Maringer et al., 2017; Scott et al., 2010) . To determine the effect of co-replicating Wolbachia on the insect-specific flavivirus CFAV, supernatant was harvested from Wolbachia-free Aag2 cells as well as Aag2 cells infected with wMel or wMelPop-CLA and screened by RT-PCR (Fig. 1A) . While CFAV replication was detected in the control Aag2 Wolbachia-free line, no replication was detected in cells persistently infected with Wolbachia at either time point. To further elucidate if this was due to Wolbachia actively supressing this virus, cell lines were treated with tetracycline for 3 successive passages. The presence of infectious CFAV was not detected by ELISA in tetracycline-treated wMel or wMelPop-CLA lines upon inoculation or an additional passage of supernatant on C6/36 cells (Table 1) . Absence of flavivirus replication was further confirmed by CFAV-specific RT-PCR from supernatant harvested from passage 1 (Fig. 1B) .
Wolbachia does not affect PCLV replication in co-infected Aag2 cells
To determine if Wolbachia supressed the insect-specific bunyavirus PCLV in co-infected Aag2 cell culture, supernatant obtained from Wolbachia-free Aag2 cell and Aag2 cells infected with wMel or wMelPop-CLA was screened by RT-PCR. In contrast to what was observed with CFAV, PCLV was detected in the Wolbachia-free Aag2 line as well as both Wolbachia infected lines. To further confirm if this was an active viral infection capable of infecting new cells, supernatant harvested from both Wolbachia untreated and tetracycline-treated lines was inoculated onto the permissive C6/36 line for 2 successive passages. PCLV replication was confirmed by RT-PCR in C6/36 supernatant obtained from passage 1 suggesting infectious PCLV was produced in the Aag2 line.
PCLV replication detected in wMel and wMelPop-CLA infected RML-12 cell lines
To investigate the potential of PCLV to be detected in other Wolbachia infected cell lines, Ae. albopictus, Wolbachia-free RML-12 cells as well as RML-12 cells stably infected with wMel and wMelPop-CLA were assessed. PCLV was detected by RT-PCR in supernatant from RML-12 lines regardless of Wolbachia infection (Fig. 2) . All three cell lines were assessed for CFAV infection by RT-PCR and found to be uninfected (Fig. 2) . Furthermore, to determine if either +ssRNA or dsRNA viruses were present, C6/36 monolayers infected with supernatant harvested from these lines was assessed by fixed cell ELISA. No reactivity was observed in passage 0 or passage 1 using the anti-dsRNA mAb 3G1 demonstrating that this cell line was not persistently infected by these virus types (Table 2) .
Discussion
The endosymbiont Wolbachia been widely studied for its pathogen blocking phenotype against +ssRNA viruses (Aliota et al., 2016; Chrostek et al., 2013; Ferguson et al., 2015; Glaser and Meola, 2010; Moreira et al., 2009; Osborne et al., 2012) . However, co-infection of Wolbachia with viruses which exhibit different transmission (vertical or venereal) and replication strategies (-ssRNA or dsRNA) in mosquitoes are yet to be widely explored. Recently, ISVs have been isolated in high prevalence from both wild type and laboratory-reared mosquitoes (Blitvich and Firth, 2015; Bolling et al., 2015; . These isolations form an interesting addition to arboviral research as in vitro and in vivo investigations into the impact of these viruses within the mosquito virome have demonstrated that ISVs can either enhance or suppress the replication of closely related, medically significant pathogens (Bolling et al., 2012; Hall-Mendelin et al., 2016; Newman et al., 2011) . The mosquito species Ae. aegypti is not only a significant vector of human pathogens DENV, Zika virus and Yellow fever but also a known carrier of the ISVs CFAV and PCLV (Cook et al., 2006; Yamao et al., 2009 ). As Ae. aegypti is the focus of Wolbachia related research in mosquitoes (Ferguson et al., 2015; Frentiu et al., 2014; Moreira et al., 2009) it is likely that this bacterium is not only interacting with viruses known to cause disease but also with the ISVs that persistently infect this species.
To further assess these interactions between Wolbachia and viruses which persistently infect mosquitoes, Aag2 wMel and wMelPop-CLA cell lines were evaluated for the presence of two ISVs (CFAV and PCLV) previously shown to replicate within the parental Aag2 cell line (Maringer et al., 2017; Stollar and Thomas, 1975) . The replication of CFAV, a member of the Flaviviridae family, was restricted by Wolbachia as this virus could not be detected by RT-PCR in supernatant harvested from Aag2 wMel and wMelPop-CLA lines. These results are consistent with studies based on RT-PCR alone by Schnettler et al. (2016) which reported suppression of CFAV in the wMelPop-CLA line. As the presence of infectious CFAV had not been described by previous studies, it was assessed by the inoculation of permissive, Ae. albopictus (C6/36) cells with supernatant harvested from the Aag2 line with or without Wolbachia. CFAV was not detected by anti-dsRNA ELISA from passaged, wMel, wMelPop-CLA or matched tetracycline treated lines. This study and Schnettler et al. (2016) both contrast the observations reported in Zhang et al. (2016) as infectious CFAV could not be recovered after tetracycline treatment. As density is a well described factor contributing to Wolbachia-mediated suppression, Zhang et al. (2016) hypothesised that the difference in CFAV replication may have been due to lower Wolbachia densities maintained in the line. However, as it's likely that the CFAV infection was lost prior to both the screening by this study and that of Schnettler et al. (2016) , it is difficult to determine how density affects the replication of persistent ISF infections in cell lines without observations over multiple passages.
Viral clearance of the insect-specific, -ssRNA bunyavirus PCLV was not observed in either wMel-or wMelPop-CLA-infected Aag2 or RML-12 lines. Consistent with Schnettler et al. (2016) , PCLV was detected by RT-PCR in supernatant harvested from Wolbachia-infected Aag2 cells and in inoculated C6/36 cells. (Fig. 1A and B) . Furthermore, additional assessment of Aedes derived RML-12 cell lines containing Wolbachia, found that all cell lines were persistently infected with PCLV but no dsRNA or +ssRNA viruses. As PCLV has only been identified from Ae. aegypti mosquitoes and the RML-12 line was reported to have originated from this species it is possible that like CFAV, the viral infection was established at the generation of the line (Chandler et al., 2014; Maringer et al., 2015; Peleg, 1968; Stollar and Thomas, 1975) . However, recent analysis by McLean et al. (2015) and Voronin et al. (2010) which demonstrated that the RML-12 line was derived from Ae albopictus may contradict this hypothesis as it suggests that the line may have been either initially misidentified or was contaminated with a second cell type during passage. While the permissibility of the RML-12 line to persistent PCLV infection raises further investigation about Ae. albopictus as a natural reservoir for this virus, the inability of wMel and wMelPop-CLA strains to efficiently clear co-infected cultures suggest that PCLV evades Wolbachia by mechanisms associated with the replication strategies of this virus rather than by species-specific interactions.
Interestingly, this and Schnettler et al. (2016) are not the only reports of Wolbachia failing to supress replication of -ssRNA viruses. Schultz et al. (2018) determined that the replication of La Crosse virus (LACV; Bunyaviridae) and vesicular stomatitis virus (VSV; Rhabdoviridae) was not affected by Wolbachia (wStri) in Ae. albopictus cells while Parry and Asgari (2018) demonstrated that endogenous Aedes anphevirus (AeAV; order Mononegavirales) could be isolated from both wMelPop-CLA and wMelPop-CLA TET cell lines. Furthermore, in vivo studies by Glaser and Meola (2010) demonstrated that Wolbachia did not suppress the replication of LACV in co-infected Drosophila melanogaster and more recently Dodson et al. (2017) reported that the transmission of Rift Valley fever virus (RFV; Bunyaviridae) was not restricted 
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Conclusion
In summary, Wolbachia restricts the replication of the +ssRNA virus, CFAV, but not -ssRNA virus, PCLV, in co-infected cell culture. These results support previous studies which have suggested similar interactions (Schnettler et al., 2016; Zhang et al., 2016) while also confirming the viral clearance of CFAV by Wolbachia as no infectious virus was detected by anti-dsRNA ELISA. As ISVs display tropisms and transmission strategies generally not associated with other pathogenic arboviruses, further investigation is required to determine if this effect is observed in Ae. aegypti mosquitoes. Interestingly, to date, Wolbachia has not been shown to affect the replication of -ssRNA viruses (Dodson et al., 2017; Glaser and Meola, 2010; Parry and Asgari, 2018; Schultz et al., 2018) suggesting a new avenue to explore Wolbachia-mediated interference which may extend our understanding of the underlying mechanism of interference.
Methods
Cell line maintenance
C6/36 and RML-12 (Ae. albopictus) cells were cultured at 28°C in RPMI 1640 medium (C6/36) or Schneider's Drosophila/Mitsuhashi and Maramorosch 50:50 medium (RML-12) supplemented with 10% foetal bovine serum (FBS) and L-glutamine. Ae. aegypti Aag2, Aag2 wMel and Aag2 wMelPop-CLA cells were cultured in Schneider's/Grace's insect medium (50:50) containing 10% FBS and L-glutamine at 26°C. Tetracycline treated lines were generated from Aag2, Aag2 wMel and Aag2 wMelPop-CLA by the addition of 10 μg/ml of tetracycline to the maintenance media for 3 successive passages.
Virus identification and isolation from mosquito cell lines
Following the final tetracycline (tet)-treatment of Aag2, Aag2 wMel and Aag2 wMelPop-CLA lines, supernatant from each untreated and tettreated line was harvested. Two hundred microliters of supernatant from each Wolbachia untreated and tet-treated line as well as medium used to culture Aag2 (mock) was inoculated onto semi-confluent C6/36 cells and incubated at 28°C for 5-7 days. Supernatant was harvested and immediately passaged onto fresh C6/36 cells for an additional passage, with the remaining supernatant used for RNA extraction. Monolayers were then fixed using 4% formaldehyde/0.5% Triton X for 4 h at 4°C. To determine if ISVs were present in other Aedes-derived, Wolbachia-infected lines, RML-12 cells (wt, wMel or wMelPop-CLA) were assessed (with the exception of tetracycline treatment) by the methods described above. Fixed-cell ELISA was performed using the anti-dsRNA mAb 3G1 as per previously described methods (O'Brien et al., 2015) . RNA was extracted from 100 μl of culture supernatant of all samples using the RNeasy mini kit (Qiagen). Five-microliters of purified RNA was then screened by RT-PCR (SuperScript III One-Step RT-PCR System with Platinum Taq DNA) using CFAV and PCLV-specific primers from Schnettler et al. (2016) . As additional confirmation of virus isolation, RNA was also extracted directly from supernatant harvested from Aag2, Aag2 wMel and Aag2 wMelPop-CLA cell lines.
